[go: up one dir, main page]

AU2002338265A1 - Molecules for disease detection and treatment - Google Patents

Molecules for disease detection and treatment

Info

Publication number
AU2002338265A1
AU2002338265A1 AU2002338265A AU2002338265A AU2002338265A1 AU 2002338265 A1 AU2002338265 A1 AU 2002338265A1 AU 2002338265 A AU2002338265 A AU 2002338265A AU 2002338265 A AU2002338265 A AU 2002338265A AU 2002338265 A1 AU2002338265 A1 AU 2002338265A1
Authority
AU
Australia
Prior art keywords
molecules
treatment
disease detection
disease
detection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002338265A
Inventor
Stefan R. Amshey
Alice J. Chen
Joyce Chinn
Abel Daffo
Christopher R. Dahl
Tam C. Dam
Sean C. Daugherty
Marie H. David
Gerard E. Dufour
Edward H. Gerstin Jr.
Darryl Gietzen
Bernard Harris
Jennifer L. Jackson
Anissa L. Jones
Yael Kleefeld
Ruth Y. Lan
Samantha A. Lewis
Tommy F. Liu
Audrey Lo
Rakesh Marwaha
Vincent Z. Mullahy-Flores
Duy-Viet An Nguyen
Scott R. Panzer
Careyna H. Peralta
Alanna-Phung B. Tran
Olivia Tuason
Michael E. Urashka
Pierre E. Yap
Jimmy Y. Yu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Genomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Genomics Inc filed Critical Incyte Genomics Inc
Publication of AU2002338265A1 publication Critical patent/AU2002338265A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU2002338265A 2001-03-28 2002-03-27 Molecules for disease detection and treatment Abandoned AU2002338265A1 (en)

Applications Claiming Priority (19)

Application Number Priority Date Filing Date Title
US27961901P 2001-03-28 2001-03-28
US60/279,619 2001-03-28
US28006801P 2001-03-29 2001-03-29
US28006701P 2001-03-29 2001-03-29
US60/280,068 2001-03-29
US60/280,067 2001-03-29
US29128001P 2001-05-16 2001-05-16
US60/291,280 2001-05-16
US29184901P 2001-05-17 2001-05-17
US29182901P 2001-05-17 2001-05-17
US60/291,849 2001-05-17
US60/291,829 2001-05-17
US29942801P 2001-06-19 2001-06-19
US60/299,428 2001-06-19
US30000101P 2001-06-20 2001-06-20
US29977601P 2001-06-20 2001-06-20
US60/300,001 2001-06-20
US60/299,776 2001-06-20
PCT/US2002/009944 WO2002079449A2 (en) 2001-03-28 2002-03-27 Molecules for disease detection and treatment

Publications (1)

Publication Number Publication Date
AU2002338265A1 true AU2002338265A1 (en) 2002-10-15

Family

ID=27578771

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2002338265A Abandoned AU2002338265A1 (en) 2001-03-28 2002-03-27 Molecules for disease detection and treatment
AU2002344208A Abandoned AU2002344208A1 (en) 2001-03-28 2002-03-27 Molecules for diagnostics and therapeutics

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2002344208A Abandoned AU2002344208A1 (en) 2001-03-28 2002-03-27 Molecules for diagnostics and therapeutics

Country Status (4)

Country Link
EP (1) EP1383894A2 (en)
AU (2) AU2002338265A1 (en)
CA (2) CA2442705A1 (en)
WO (2) WO2002097031A2 (en)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7244827B2 (en) 2000-04-12 2007-07-17 Agensys, Inc. Nucleic acid and corresponding protein entitled 24P4C12 useful in treatment and detection of cancer
US6943235B1 (en) 1999-04-12 2005-09-13 Agensys, Inc. Transmembrane protein expressed in prostate cancer
WO2002074906A2 (en) * 2001-03-16 2002-09-26 Eli Lilly And Company Lp mammalian proteins; related reagents
US7736654B2 (en) 2001-04-10 2010-06-15 Agensys, Inc. Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers
EP1310552B1 (en) * 2001-11-09 2007-06-13 Proteologics, Inc. Posh nucleic acids, polypeptides and related methods
US8753822B2 (en) * 2001-12-04 2014-06-17 Wayne State University Neoepitope detection of disease using protein arrays
EP1511772B1 (en) * 2002-05-28 2011-11-23 Omrix Biopharmaceuticals Inc. Method for obtaining anti-idiotype antibodies
US20040053304A1 (en) 2002-06-05 2004-03-18 Case Western Reserve University Methods and compositions for detecting cancers
WO2004016733A2 (en) 2002-08-16 2004-02-26 Agensys, Inc. Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
TW200418988A (en) * 2002-09-30 2004-10-01 Oncotherapy Science Inc Method for diagnosing prostate cancer
AU2003271149A1 (en) * 2002-10-11 2004-05-04 Yamanouchi Pharmaceutical Co., Ltd. Method of screening remedy for renal failure
AU2003302386B2 (en) * 2002-11-26 2010-04-01 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
US7396666B2 (en) * 2002-12-27 2008-07-08 National Institute Of Advanced Industrial Science And Technology Glycosyltransferase, nucleic acid encoding the glycosyltransferase and method of testing canceration using the nucleic acid
GB0315827D0 (en) * 2003-07-05 2003-08-13 Imp College Innovations Ltd Methods
WO2005117538A2 (en) * 2004-04-12 2005-12-15 The Trustees Of Columbia University In The City Of New York METHODS AND COMPOSITIONS FOR INHIBITING ABAD/Aβ PROTEIN INTERACTION
EP1627922A1 (en) * 2004-08-18 2006-02-22 Sanofi-Aventis Deutschland GmbH Method of screening for a carnitine transporter agonist or antagonist and its uses
GB0423126D0 (en) * 2004-10-18 2004-11-17 Ares Trading Sa Protein
US7727725B2 (en) 2006-04-27 2010-06-01 Celera Corporation Genetic polymorphisms associated with liver fibrosis, methods of detection and uses thereof
WO2008070090A2 (en) 2006-12-05 2008-06-12 Oncomed Pharmaceuticals, Inc. Compositions and methods for diagnosing and treating cancer
WO2010053772A2 (en) 2008-10-29 2010-05-14 The Regents Of The University Of California Disease-associated antigens and methods of use thereof
CA2758687A1 (en) 2008-11-14 2010-05-20 Gen-Probe Incorporated Compositions, kits and methods for detection of campylobacter nucleic acid
US20150231215A1 (en) 2012-06-22 2015-08-20 Randolph J. Noelle VISTA Antagonist and Methods of Use
NZ737844A (en) * 2010-03-26 2022-09-30 Dartmouth College Vista regulatory t cell mediator protein, vista binding agents and use thereof
US10745467B2 (en) 2010-03-26 2020-08-18 The Trustees Of Dartmouth College VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders
CN103209987B (en) 2010-09-22 2017-06-06 艾丽奥斯生物制药有限公司 substituted nucleotide analogs
HK1203075A1 (en) 2011-12-22 2015-10-16 艾丽奥斯生物制药有限公司 Substituted phosphorothioate nucleotide analogs
NZ631601A (en) 2012-03-21 2016-06-24 Alios Biopharma Inc Solid forms of a thiophosphoramidate nucleotide prodrug
WO2013142157A1 (en) 2012-03-22 2013-09-26 Alios Biopharma, Inc. Pharmaceutical combinations comprising a thionucleotide analog
US9890215B2 (en) 2012-06-22 2018-02-13 King's College London Vista modulators for diagnosis and treatment of cancer
BR112014032276A2 (en) 2012-06-22 2017-11-28 King S College London vista-ig constructs and the use of vista-ig for the treatment of autoimmune, allergic and inflammatory disorders
CN109793893B (en) 2012-09-07 2023-05-26 达特茅斯大学理事会 VISTA modulators for diagnosis and treatment of cancer
US11014987B2 (en) 2013-12-24 2021-05-25 Janssen Pharmaceutics Nv Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
IL301714A (en) 2013-12-24 2023-05-01 Janssen Pharmaceutica Nv Anti-vista antibodies and fragments
WO2015191881A2 (en) 2014-06-11 2015-12-17 Green Kathy A Use of vista agonists and antagonists to suppress or enhance humoral immunity
EP3226900A4 (en) 2014-12-05 2018-09-19 Immunext, Inc. Identification of vsig8 as the putative vista receptor and its use thereof to produce vista/vsig8 modulators
EP3722314A1 (en) 2015-06-24 2020-10-14 Janssen Pharmaceutica NV Anti-vista antibodies and fragments
MX2018009800A (en) 2016-02-12 2018-11-09 Janssen Pharmaceutica Nv Anti-vista (b7h5) antibodies.
KR20250153855A (en) 2016-04-15 2025-10-27 이뮤넥스트, 인크. Anti-human vista antibodies and use thereof
EP3814371A4 (en) * 2018-06-26 2022-07-20 Duke University SYNTHETIC ODOR RECEPTORS
CN110714017B (en) * 2019-11-06 2023-09-01 河南师范大学 Koi ptps gene, encoded protein and application
CN111621525B (en) * 2020-06-18 2021-04-23 中赛干细胞基因工程有限公司 Application of STX1B gene in promoting growth and differentiation of human adipose-derived mesenchymal stem cells
CN114317732B (en) * 2021-04-08 2023-08-18 博尔诚（北京）科技有限公司 Composition for lung cancer screening and application thereof

Also Published As

Publication number Publication date
WO2002079449A2 (en) 2002-10-10
WO2002097031A3 (en) 2005-05-12
EP1383894A2 (en) 2004-01-28
WO2002097031A2 (en) 2002-12-05
WO2002079449A3 (en) 2003-03-20
CA2447183A1 (en) 2002-10-10
AU2002344208A1 (en) 2002-12-09
AU2002344208A8 (en) 2005-11-17
CA2442705A1 (en) 2002-12-05

Similar Documents

Publication Publication Date Title
AU2002338265A1 (en) Molecules for disease detection and treatment
AU2001255655A1 (en) Treatment analysis systems and methods
AUPP784398A0 (en) Kidney disease detection and treatment
AU2002258388A1 (en) Narc8 programmed cell-death-associated molecules and uses thereof
AU2002318356A1 (en) Protein modification and maintenance molecules
AU2002220266A1 (en) Methods for the identification and the treatment of cardiovascular disease
AU2002329784A1 (en) Molecules for disease detection and treatment
AU2002349268A1 (en) Medicine for preventing and treating bromidrosis
AU2002364890A1 (en) Molecules for disease detection and treatment
AU2002327945A1 (en) Human delta-n p73 molecules and uses thereof
AU2001241709A1 (en) Molecules for disease detection and treatment
AU2003205174A1 (en) Molecules for disease detection and treatment
AU2002243539A1 (en) Molecules for disease detection and treatment
AU2002347899A1 (en) Molecules for disease detection and treatment
AU2002253883A1 (en) Protein modification and maintenance molecules
GB0115780D0 (en) Therapeutic molecules and uses thereof
AU2002359567A1 (en) Molecules for disease detection and treatment
AU2002248723A1 (en) Molecules for disease detection and treatment
AU2002239543A1 (en) Molecules for disease detection and treatment
AU2002320630A1 (en) Detecting and treating reproductive tract disorders
AU2002343515A1 (en) Protein modification and maintenance molecules
AU5319400A (en) Molecules for disease detection and treatment
AU2002320026A1 (en) Molecules for disease detection and treatment
AU2003231245A1 (en) Molecules for disease detection and treatment
EP1390410A4 (en) Molecules for disease detection and treatment

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase